Member Info for LiquidSilver

100k buyer on the bell.
Someone soaking up nice chunks

Looks like the TR1 holder is still buying at the 0.6 level.
Cant be much stock remaining under 0.6 and then a squeeze higher.
Is he going for 7/8/9 or 10% of the company?

Any news on Lithium in Zimbabwe and Arkle could have a serious run up. GL.

Bought KAV today. Seems a very good level and market cap. Small spike a few weeks ago from 1 to 1.5p showing on news the price moves quickly.

Potential JV RNS and new project alluded too a month or two ago by Ben.

Assays due and other buyers around at this level.

market is definitely looking for stock.

Institutions sold as went under their market cap threshold. Simple as that and no drama as retail investors would suggest.
Kave had his own opinions and sold but that resistance is now gone and an opportunity to buy.

Company and nomad need to update the market on the production for the new Saliva pregnancy test and launch.
Think people realise this will be soon and there is limited stock available hence the squeeze.
Once the company RNS's they have started production for the new test a wider audience will learn about the product and its potential.

That worked sell and volume has been in the pipeline for months.

Its finally been filled by the 11% copper discovery at Minto.

The price action a few days ago soaked up that worked sell (2% of the company) and the subsequent action showed the MM's had limited to no stock at this £1.5/2m market cap level.

The value of Minto currently is worth over £5m and that is with Minto pulling back from their IPO at over $2 to $1.2.
If you believe in Copper then Minto and Pere are totally undervalued with a squeeze potential in Pembridge..

They are overdue a payment of $500k and another $500k due in June and $1m in September.
This stock was trading between 5-8p when Copper was these levels and slightly higher. Also note the CEO owns 22% and bought 550k shares at 2.1p on market as well as 300,401 @ 3.7p July last year on market & £80,000 @ 5p.

Not a trading stock until Salistick launch next month?!
Its a building stock. Price isn't the most important factor, more the volume and value imo. Gluck

No, Abingdon (co branding) are producing the strip and exclusive distributor for the UK and Ireland.

The packaging is being done in Israel
There will also be an advertising campaign before launch in May.
Totally patented and a world's first.

Very exciting couple of months ahead.

https://www.salignostics.com/

Imagine the sales of this product via Amazon and other platforms.

Less than 20 trading days before IM news. Could see a lot of traders into H&W this week squeezing the price closer to 20p

I can see 10-12p quite easily with what’s to come, why wait for 25p?!

6p is a good price level imo

https://www.mirror.co.uk/news/uk-news/worlds-first-lateral-flow-covid-29271390?int_source=amp_continue_reading&int_medium=amp&int_campaign=continue_reading_button#amp-readmore-target

On launch this is going to be huge for Abingdon Health brand awareness and revenues. I can see the launch being in national press and even on Sky News and other platforms if Walbrook PR do their job properly.

It is a period of time to buy shares in ABDX around 6/7p before the storm of a wider audience, momentum and sentiment drives the share price a lot higher imo.

Won’t be long before it’s launched on Amazon and national retailers will want this innovative product.

The door has already being opened with Lloyds Pharmacy…who’s next? Boots? Tesco, Asda, Sainsbury’s etc?

https://lloydspharmacy.ie/collections/abingdon-self-tests

https://youtu.be/pwlBzpHrkC8

coming soon on Amazon

Abingdon Self testing has started to sell on Amazon some of the AST range and will roll out other tests, revenues will be exciting from this platform alone together with other contracts.

Will also be selling Salistick/CYD in the near future on Amazon and other platforms!
Salistick being co-branded will also help general Abingdon Self Test brand awareness.

'expected to be significantly improved in H2 2023 and FY 2023 revenues are expected to be materially higher than FY 2022 revenues of £2.8m.'

'signed another two CDMO contracts post-period end and these projects are in the process of onboarding.

· Based on current trading to date and contracted business in H2 2023, the Board is confident that second half revenues will be materially ahead of H1 2023.'

https://www.judiciaryni.uk/judicial-decisions/2023-nikb-41

No Gas Caverns and Friends of the Earth have had two applications thrown out by the judge and full costs awarded against them. This could be very significant next week!

https://www.harland-wolff.com/investors/projects/islandmagee-gas-storage-project/

Abingdon Health have now started to sell a couple of tests via Amazon.
I'm sure the whole range will now start to be rolled out and generate very good revenues

https://www.amazon.co.uk/Abingdon-Simply-Approved-Fertility-Self-Test/dp/B0BXM4CMZ9

The company has certainly turned a corner.
I waited yesterday for a potential pull back to buy further but the support was there at 5.5-6.5p. Gives me confidence now at higher levels.

Director/PDMR Dealing

York, U.K. 26 September 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces that, in addition to the Director Dealing announced on 16 September 2023 (https://polaris.brighterir.com/public/abingdon_health/news/rns/story/w6zdykr), on 23 September 2022, Chris Yates, Chief Executive Officer purchased a total of 125,000 ordinary shares of 0.25 pence each ("Ordinary Shares") over two trades (the "Purchases") at a price of 7.3 pence per Ordinary Share.

Hint, it's going over 7.3p?!

‘Strong revenue traction’
‘Manufacturing’
‘The Company's product revenue growth’

‘The Company is currently working with a number of new customers across 11 different contract service projects in multiple areas (vs three as at 1 July 2022) with two additional contracts signed, work on which will commence in Q4 2023.’

‘expected to be significantly improved in H2 2023’ (hint, he already knows)

‘FY 2023 revenues are expected to be materially higher than FY 2022 revenues of £2.8m’ (hint, he already knows)

‘Based on current trading to date and contracted business in H2 2023, the Board is confident that second half revenues will be materially ahead of H1 2023’ (hint, he already knows!!)

‘Dr Chris Hand, Non-Executive Chairman of Abingdon Health plc, said: "Abingdon continues to build revenue across lateral flow development, technical transfer and manufacture’

How many hints does he need in an RNS?

Even if it is slightly lower due to development costs and some panic sell...it will be bought up just after.

The business has turned a corner and selling product....need to see past any cash costs and understand 99% panic is built in and the last placing was 25p. CEO bought stock on market in the 6p's because he could. Gap up above 10p short term and next set of accounts and growing revenues we will be closer to 25p again.

Bought today and looking to build at 4.5-5.5p level.
Cash, business in the right direction and board heavily invested and at 25p.
Makes sense to me. Gluck